Cargando…

Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study

BACKGROUND: Management of epilepsy during pregnancy in a resource-limited setting (RLS) is challenging. This study aimed to assess obstetric outcomes and effects on babies of women with epilepsy (WWE) exposed to Anti-epileptic drugs (AEDs) compared to non-exposed controls in a RLS. METHODS: Pregnant...

Descripción completa

Detalles Bibliográficos
Autores principales: Galappatthy, Priyadarshani, Liyanage, Chiranthi Kongala, Lucas, Marianne Nishani, Jayasekara, Dilini T. L. M., Abhayaratna, Sachith Aloka, Weeraratne, Chamari, De Abrew, Kusum, Gunaratne, Padma Sriyani, Gamage, Ranjani, Wijeyaratne, Chandrika N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000926/
https://www.ncbi.nlm.nih.gov/pubmed/29898689
http://dx.doi.org/10.1186/s12884-018-1857-3
_version_ 1783331865089802240
author Galappatthy, Priyadarshani
Liyanage, Chiranthi Kongala
Lucas, Marianne Nishani
Jayasekara, Dilini T. L. M.
Abhayaratna, Sachith Aloka
Weeraratne, Chamari
De Abrew, Kusum
Gunaratne, Padma Sriyani
Gamage, Ranjani
Wijeyaratne, Chandrika N.
author_facet Galappatthy, Priyadarshani
Liyanage, Chiranthi Kongala
Lucas, Marianne Nishani
Jayasekara, Dilini T. L. M.
Abhayaratna, Sachith Aloka
Weeraratne, Chamari
De Abrew, Kusum
Gunaratne, Padma Sriyani
Gamage, Ranjani
Wijeyaratne, Chandrika N.
author_sort Galappatthy, Priyadarshani
collection PubMed
description BACKGROUND: Management of epilepsy during pregnancy in a resource-limited setting (RLS) is challenging. This study aimed to assess obstetric outcomes and effects on babies of women with epilepsy (WWE) exposed to Anti-epileptic drugs (AEDs) compared to non-exposed controls in a RLS. METHODS: Pregnant WWE were recruited from antenatal and neurology clinics of a tertiary care hospitals in Sri Lanka. Patients were reviewed in each trimester and post-partum. Medication adherence, adverse effects, seizure control and carbamazepine blood levels were monitored. Post-partum, measurements for anthropometric and dysmorphic features of the babies and congenital abnormalities were recorded. Age and sex matched babies not exposed to AED recruited as controls were also examined. RESULTS: Ninety-six pregnant WWE were recruited (mean period of gestation 22.9 weeks). Mean age was 28 years and 48(50%) were primigravidae. Fifty percent (48) were on monotherapy, while 23.8, 15.9 and 4.1% were on two, three and four AEDs respectively. AEDs in first trimester (TM1) were carbamazepine (71%), valproate (25.8%) clobazam (29.5%), lamotrigine (7%) topiramate (5%) and others (3.4%). Sodium valproate use reduced significantly from T1 to T2(p < 0.05). Sub-therapeutic carbamazepine levels correlated positively (r = 0.547) with poor medication adherence (p = 0.009) and negatively (r = 0.306) with adverse effects (p = 0.002). Seventy-six WWE completed follow-up reporting w 75 (98.6%) live births and one T1 miscarriage (1.3%). Three (4.3%) were preterm. Majority (73.33%) were normal vaginal deliveries. Cesarean sections were not increased in WWE. Fifty-nine (61.45%) babies were examined. For those examined during infancy, 53 age and sex matched controls were recruited and examined.. Congenital abnormalities occurred in 5 (9.43%) babies of WWE [atrio-ventricular septal defect (2), renal hypoplasia (1), cryptorchidism (1), microcephaly (1)] compared to 2 (3.77%) in controls (2 microcephaly; p = 0.24). Fetal exposure to AEDs increased a risk of low birth weight (RR 2.8; p = 0.049). Anthropometric parameters of AED exposed babies were lower at birth but not statistically significant between the two groups (weight p = 0.263, length p = 0.363, occipito-frontal circumference (OFC) p = 0.307). However, weight (p = 0.009), length (p = 0.016) and OFC (p = 0.002) were significantly lower compared to controls at an average of 3.52 months. CONCLUSION: Most pregnancies are unplanned in the RLS studied, and AEDs were altered during pregnancy. Congenital anomalies occurred at rates comparable to previous reports. Fetal exposure to AED had growth retardation in infancy compared to non-exposed babies.
format Online
Article
Text
id pubmed-6000926
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60009262018-06-25 Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study Galappatthy, Priyadarshani Liyanage, Chiranthi Kongala Lucas, Marianne Nishani Jayasekara, Dilini T. L. M. Abhayaratna, Sachith Aloka Weeraratne, Chamari De Abrew, Kusum Gunaratne, Padma Sriyani Gamage, Ranjani Wijeyaratne, Chandrika N. BMC Pregnancy Childbirth Research Article BACKGROUND: Management of epilepsy during pregnancy in a resource-limited setting (RLS) is challenging. This study aimed to assess obstetric outcomes and effects on babies of women with epilepsy (WWE) exposed to Anti-epileptic drugs (AEDs) compared to non-exposed controls in a RLS. METHODS: Pregnant WWE were recruited from antenatal and neurology clinics of a tertiary care hospitals in Sri Lanka. Patients were reviewed in each trimester and post-partum. Medication adherence, adverse effects, seizure control and carbamazepine blood levels were monitored. Post-partum, measurements for anthropometric and dysmorphic features of the babies and congenital abnormalities were recorded. Age and sex matched babies not exposed to AED recruited as controls were also examined. RESULTS: Ninety-six pregnant WWE were recruited (mean period of gestation 22.9 weeks). Mean age was 28 years and 48(50%) were primigravidae. Fifty percent (48) were on monotherapy, while 23.8, 15.9 and 4.1% were on two, three and four AEDs respectively. AEDs in first trimester (TM1) were carbamazepine (71%), valproate (25.8%) clobazam (29.5%), lamotrigine (7%) topiramate (5%) and others (3.4%). Sodium valproate use reduced significantly from T1 to T2(p < 0.05). Sub-therapeutic carbamazepine levels correlated positively (r = 0.547) with poor medication adherence (p = 0.009) and negatively (r = 0.306) with adverse effects (p = 0.002). Seventy-six WWE completed follow-up reporting w 75 (98.6%) live births and one T1 miscarriage (1.3%). Three (4.3%) were preterm. Majority (73.33%) were normal vaginal deliveries. Cesarean sections were not increased in WWE. Fifty-nine (61.45%) babies were examined. For those examined during infancy, 53 age and sex matched controls were recruited and examined.. Congenital abnormalities occurred in 5 (9.43%) babies of WWE [atrio-ventricular septal defect (2), renal hypoplasia (1), cryptorchidism (1), microcephaly (1)] compared to 2 (3.77%) in controls (2 microcephaly; p = 0.24). Fetal exposure to AEDs increased a risk of low birth weight (RR 2.8; p = 0.049). Anthropometric parameters of AED exposed babies were lower at birth but not statistically significant between the two groups (weight p = 0.263, length p = 0.363, occipito-frontal circumference (OFC) p = 0.307). However, weight (p = 0.009), length (p = 0.016) and OFC (p = 0.002) were significantly lower compared to controls at an average of 3.52 months. CONCLUSION: Most pregnancies are unplanned in the RLS studied, and AEDs were altered during pregnancy. Congenital anomalies occurred at rates comparable to previous reports. Fetal exposure to AED had growth retardation in infancy compared to non-exposed babies. BioMed Central 2018-06-14 /pmc/articles/PMC6000926/ /pubmed/29898689 http://dx.doi.org/10.1186/s12884-018-1857-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Galappatthy, Priyadarshani
Liyanage, Chiranthi Kongala
Lucas, Marianne Nishani
Jayasekara, Dilini T. L. M.
Abhayaratna, Sachith Aloka
Weeraratne, Chamari
De Abrew, Kusum
Gunaratne, Padma Sriyani
Gamage, Ranjani
Wijeyaratne, Chandrika N.
Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study
title Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study
title_full Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study
title_fullStr Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study
title_full_unstemmed Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study
title_short Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study
title_sort obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000926/
https://www.ncbi.nlm.nih.gov/pubmed/29898689
http://dx.doi.org/10.1186/s12884-018-1857-3
work_keys_str_mv AT galappatthypriyadarshani obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy
AT liyanagechiranthikongala obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy
AT lucasmariannenishani obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy
AT jayasekaradilinitlm obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy
AT abhayaratnasachithaloka obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy
AT weeraratnechamari obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy
AT deabrewkusum obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy
AT gunaratnepadmasriyani obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy
AT gamageranjani obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy
AT wijeyaratnechandrikan obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy